Next Article in Journal
Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials
Next Article in Special Issue
Deep Sequencing and Screening of Differentially Expressed MicroRNAs Related to Milk Fat Metabolism in Bovine Primary Mammary Epithelial Cells
Previous Article in Journal
Food-Derived Bioactives Can Protect the Anti-Inflammatory Activity of Cortisol with Antioxidant-Dependent and -Independent Mechanisms
Previous Article in Special Issue
miR-9-5p, miR-675-5p and miR-138-5p Damages the Strontium and LRP5-Mediated Skeletal Cell Proliferation, Differentiation, and Adhesion
Open AccessArticle

Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis

Department of Biomedical Engineering, Indiana University—Purdue University Indianapolis, Indianapolis, IN 46202, USA
Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie 514-8507, Japan
Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8650, Japan
Author to whom correspondence should be addressed.
Academic Editors: Y-h. Taguchi and Charles J. Malemud
Int. J. Mol. Sci. 2016, 17(2), 240;
Received: 15 December 2015 / Revised: 6 February 2016 / Accepted: 6 February 2016 / Published: 16 February 2016
(This article belongs to the Special Issue MicroRNA Regulation)
MicroRNAs (miRNAs) are small non-coding RNAs that play a mostly post-transcriptional regulatory role in gene expression. Using RAW264.7 pre-osteoclast cells and genome-wide expression analysis, we identified a set of miRNAs that are involved in osteoclastogenesis. Based on in silico analysis, we specifically focused on miR-222-3p and evaluated its role in osteoclastogenesis. The results show that the inhibitor of miR-222-3p upregulated the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) and tartrate-resistant acid phosphatase (TRAP), while its mimicking agent downregulated their mRNA levels. Western blot analysis showed that its inhibitor increased the protein levels of TRAP and cathepsin K, while its mimicking agent decreased their levels. Genome-wide mRNA expression analysis in the presence and absence of receptor activator of nuclear factor κ-B ligand (RANKL) predicted c-Src as a potential regulatory target of miR-222-3p. Live cell imaging using a fluorescence resonance energy transfer (FRET) technique revealed that miR-222-3p acted as an inhibitor of c-Src activity, and a partial silencing of c-Src suppressed RANKL-induced expression of TRAP and cathepsin K, as well as the number of multi-nucleated osteoclasts and their pit formation. Collectively, the study herein demonstrates that miR-222-3p serves as an inhibitor of osteoclastogenesis and c-Src mediates its inhibition of cathepsin K and TRAP. View Full-Text
Keywords: microarray; miRNA; osteoclastogenesis; RAW264.7 cells; c-Src microarray; miRNA; osteoclastogenesis; RAW264.7 cells; c-Src
Show Figures

Figure 1

MDPI and ACS Style

Takigawa, S.; Chen, A.; Wan, Q.; Na, S.; Sudo, A.; Yokota, H.; Hamamura, K. Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis. Int. J. Mol. Sci. 2016, 17, 240.

AMA Style

Takigawa S, Chen A, Wan Q, Na S, Sudo A, Yokota H, Hamamura K. Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis. International Journal of Molecular Sciences. 2016; 17(2):240.

Chicago/Turabian Style

Takigawa, Shinya; Chen, Andy; Wan, Qiaoqiao; Na, Sungsoo; Sudo, Akihiro; Yokota, Hiroki; Hamamura, Kazunori. 2016. "Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis" Int. J. Mol. Sci. 17, no. 2: 240.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop